Objective Despite proven effectiveness, participation in traditional supervised exercise-based cardiac rehabilitation (exCR) remains low. Telehealth interventions that use information and ...
Nov 14 (Reuters) - A federal jury in California said on Friday that Apple (AAPL.O), opens new tab owes medical-monitoring technology company Masimo (MASI.O), opens new tab $634 million for infringing ...
Sudden death (SD) has traditionally been the most visible and feared complication of hypertrophic cardiomyopathy (HCM). Substantial progress in reducing the occurrence of these catastrophic events ...
The latest announcement is out from Cardiol Therapeutics ( (TSE:CRDL)). On November 13, 2025, Cardiol Therapeutics announced it received a U.S. patent allowance for its heart drugs, CardiolRx™ and CRD ...
TORONTO - Cardiol Therapeutics Inc. (NASDAQ:CRDL) (TSX:CRDL), a clinical-stage biotechnology company with a market capitalization of approximately $99 million, has received a Notice of Allowance from ...
Once issued, this new U.S. patent covers the use of CardiolRx™ and CRD-38 for a broad range of cardiac disorders, including atherosclerosis and heart failure, significantly expanding intellectual ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results